Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0769 | 0.4569 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Echinococcus granulosus | dna polymerase kappa | 0.004 | 0.012 | 0.1201 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 1 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0288 | 0.1634 | 0.1622 |
Treponema pallidum | penicillin-binding protein (pbp-1) | 0.1657 | 1 | 1 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0141 | 0.0733 | 0.123 |
Trichomonas vaginalis | glutaminase, putative | 0.0269 | 0.152 | 0.3145 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0112 | 0.056 | 0.3459 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0116 | 0.0584 | 0.87 |
Chlamydia trachomatis | transglycolase/transpeptidase | 0.0751 | 0.4461 | 0.4453 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0029 | 0.0053 | 0.0107 |
Mycobacterium tuberculosis | Probable bifunctional penicillin-binding protein 1A/1B PonA1 (murein polymerase) (PBP1): penicillin-insensitive transglycosylase | 0.0239 | 0.1334 | 0.2276 |
Loa Loa (eye worm) | glutaminase | 0.0269 | 0.152 | 1 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0112 | 0.056 | 0.8305 |
Brugia malayi | polk-prov protein | 0.0031 | 0.006 | 0.0051 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 0.3401 |
Treponema pallidum | penicillin-binding protein (pbp-2) | 0.0769 | 0.4569 | 0.4562 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.0129 | 0.0664 | 0.4165 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 0.3401 |
Mycobacterium leprae | Probable penicillin-binding membrane protein PbpB | 0.0447 | 0.2606 | 0.4431 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.012 | 0.1814 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 0.3401 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0082 | 0.0374 | 0.5254 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0112 | 0.056 | 0.844 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0112 | 0.056 | 0.0956 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 0.3401 |
Mycobacterium ulcerans | penicillin-binding lipoprotein | 0.0304 | 0.1728 | 0.1997 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0023 | 0.0014 | 0.021 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0129 | 0.0664 | 0.4165 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0031 | 0.006 | 0.0909 |
Onchocerca volvulus | 0.0234 | 0.13 | 1 | |
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0014 | 0.5 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0023 | 0.0014 | 0.0024 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0082 | 0.0374 | 0.2188 |
Mycobacterium ulcerans | DNA polymerase IV | 0.004 | 0.012 | 0.0124 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0129 | 0.0664 | 0.4012 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.004 | 0.012 | 0.1814 |
Treponema pallidum | penicillin-binding protein (pbp-3) | 0.1428 | 0.8598 | 0.8596 |
Mycobacterium ulcerans | bifunctional penicillin-binding protein 1A/1B PonA1 | 0.0769 | 0.4569 | 0.5307 |
Mycobacterium tuberculosis | Possible penicillin-binding lipoprotein | 0.0304 | 0.1728 | 0.2947 |
Mycobacterium leprae | PROBABLE BIFUNCTIONAL PENICILLIN-BINDING PROTEIN 1A/1B PONA1 (MUREIN POLYMERASE) (PBP1): PENICILLIN-INSENSITIVE TRANSGLYCOSYLASE | 0.0769 | 0.4569 | 0.7789 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0023 | 0.0014 | 0.021 |
Mycobacterium leprae | POSSIBLE PENICILLIN-BINDING LIPOPROTEIN | 0.0304 | 0.1728 | 0.2931 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0129 | 0.0664 | 1 |
Onchocerca volvulus | 0.0082 | 0.0374 | 0.2574 | |
Mycobacterium leprae | Probable penicillin-binding protein PbpA | 0.098 | 0.5863 | 1 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 1 |
Mycobacterium ulcerans | penicillin-binding membrane protein PbpB | 0.1428 | 0.8598 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0031 | 0.006 | 0.0909 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0029 | 0.0053 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0205 | 0.1127 | 0.7321 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0082 | 0.0374 | 0.2188 |
Trypanosoma brucei | unspecified product | 0.0034 | 0.0081 | 0.1216 |
Wolbachia endosymbiont of Brugia malayi | cell division protein FtsI | 0.1657 | 1 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0116 | 0.0584 | 0.8686 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 0.3401 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0129 | 0.0664 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0269 | 0.152 | 1 |
Mycobacterium tuberculosis | Probable penicillin-binding protein PbpA | 0.098 | 0.5863 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0112 | 0.056 | 0.8323 |
Mycobacterium ulcerans | bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 | 0.0529 | 0.3108 | 0.3605 |
Trichomonas vaginalis | set domain proteins, putative | 0.0234 | 0.13 | 0.2651 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0129 | 0.0664 | 0.4165 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0105 | 0.0514 | 0.3143 |
Schistosoma mansoni | lipoxygenase | 0.0116 | 0.0584 | 0.3617 |
Schistosoma mansoni | glutaminase | 0.0269 | 0.152 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.004 | 0.012 | 0.0124 |
Brugia malayi | glutaminase DH11.1 | 0.0269 | 0.152 | 1 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0129 | 0.0664 | 1 |
Plasmodium vivax | SET domain protein, putative | 0.0029 | 0.0053 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 0.3401 |
Schistosoma mansoni | lipoxygenase | 0.0081 | 0.037 | 0.216 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Mycobacterium tuberculosis | Probable bifunctional membrane-associated penicillin-binding protein 1A/1B PonA2 (murein polymerase) [includes: penicillin-insen | 0.0529 | 0.3108 | 0.5301 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.006 | 0.0051 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0082 | 0.0374 | 0.5305 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0129 | 0.0664 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0129 | 0.0664 | 1 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0112 | 0.056 | 0.3459 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0075 | 0.0331 | 0.4607 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0112 | 0.056 | 0.0636 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.0374 | 0.2188 |
Brugia malayi | Pre-SET motif family protein | 0.0205 | 0.1127 | 0.7321 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0288 | 0.1634 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 0.3401 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0075 | 0.0331 | 0.4549 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0141 | 0.0733 | 0.0838 |
Echinococcus multilocularis | dna polymerase kappa | 0.004 | 0.012 | 0.1106 |
Mycobacterium tuberculosis | Probable penicillin-binding membrane protein PbpB | 0.0447 | 0.2606 | 0.4444 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0112 | 0.056 | 0.0636 |
Mycobacterium ulcerans | penicillin-binding protein PbpA | 0.098 | 0.5863 | 0.6814 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 0.1634 | 0.3401 |
Mycobacterium leprae | PROBABLE BIFUNCTIONAL MEMBRANE-ASSOCIATED PENICILLIN-BINDING PROTEIN 1A/1B PONA2 (MUREIN POLYMERASE) [INCLUDES: PENICILLIN-INSEN | 0.0529 | 0.3108 | 0.529 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.004 | 0.012 | 0.1814 |
Mycobacterium ulcerans | glutaminase | 0.0269 | 0.152 | 0.1754 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0129 | 0.0664 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0141 | 0.0733 | 0.125 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0034 | 0.0081 | 0.1216 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CD50 (functional) | > 100 uM | Cytotoxic dose of compound required to reduce the viability of normal uninfected vero cells by 50%. | ChEMBL. | 8289203 |
ED50 (functional) | > 100 uM | Antiviral activity against HSV-1 (Herpes simplex virus) in vero cells | ChEMBL. | 8289203 |
ED50 (functional) | = 100 uM | Antiviral activity against HSV-2 (Herpes simplex virus) in vero cells | ChEMBL. | 8289203 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.